Literature DB >> 20587768

Rhabdomyolysis After LSD Ingestion.

Zachary Berrens1, Jessica Lammers, Christopher White.   

Abstract

BACKGROUND: Rhabdomyolysis involves the release of intracellular contents secondary to muscle cell injury; it generally presents with muscle pain and weakness. Illicit drugs, including phencyclidine, MDMA ("ecstasy"), and cocaine, are frequently documented as a cause of rhabdomyolysis.
OBJECTIVE: The authors review the literature on LSD-associated rhabdomyolysis.
METHOD: The authors provide a new case report of a previously health patient who suffered rhabdomyolysis after LSD ingestion.
RESULTS: Although frequently listed as a cause of rhabdomyolysis, there are only limited reports of rhabdomyolysis in patients who have ingested LSD. DISCUSSION: The discussion outlines potential mechanisms and management of LSD-associated rhabdomyolysis. Consultation psychiatrists may be called to assist in management of acute mental-status changes or agitation associated with LSD intoxication in addition to facilitating subsequent chemical-dependency treatment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20587768     DOI: 10.1176/appi.psy.51.4.356

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  5 in total

1.  Rhabdomyolysis. The role of diagnostic and prognostic factors.

Authors:  Eran Keltz; Fahmi Yousef Khan; Gideon Mann
Journal:  Muscles Ligaments Tendons J       Date:  2014-02-24

Review 2.  Accidental and iatrogenic causes of acute kidney injury.

Authors:  Katherine Twombley; Michel Baum; Jyothsna Gattineni
Journal:  Curr Opin Pediatr       Date:  2011-04       Impact factor: 2.856

3.  Diagnostic evaluation of rhabdomyolysis.

Authors:  Jessica R Nance; Andrew L Mammen
Journal:  Muscle Nerve       Date:  2015-03-14       Impact factor: 3.217

Review 4.  Assessing the risk-benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research.

Authors:  David Bender; David J Hellerstein
Journal:  Psychopharmacology (Berl)       Date:  2022-01-13       Impact factor: 4.530

Review 5.  Psychedelics.

Authors:  David E Nichols
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.